David deBronkart: Meet Dave e-paciente

30 06 2011

Dave deBronkart: e-Paciente

David deBronkart, better known as “e-paciente Dave,” He was diagnosed with cancer of the kidney in phase very advanced in January of 2007. The odds were against him, with tumours in both lungs, several bones and muscle tissue. He received good treatment, and he was able to fight to win the battle and impose on your cancer. His last treatment was in July of the 2007, and in September it was clear that he had beaten the disease.

When Dave deBronkart learned that he had a little common and terminal cancer, He led a group of other patients online and found a medical treatment until their own doctors were unaware. This saved her life. Now appealed to all patients to know their health data and talk between them for, Like this, improve health care.

deBronkart is actively participating in the opening of the medical information to patients, and it does so at an unprecedented level. Commitment to create a new dynamic in the delivery of information to patients, as well as in the access to and use of the same.

Ted.com [en línea] New York (USA): ted.com, 30 in June of 2011, [REF. June of 2011] Available on Internet:


Terminates the CANCERDIP, a European project focused on decoding the epigenetic changes that lead to cancer

27 06 2011

The European project CANCERDIP It has come to an end with an interesting contribution: a new technique to be validated by the participants of the CANCERDIP It has made the epigenomico larger map of 1.600 people. The project, funded by the European Union in the 7th framework programme for research and development, and coordinated by the director of the Epigenetics and Cancer Biology program of the Bellvitge Biomedical Research Institute (IDIBELL), Manel Esteller, Thus ends three years of research that has been carried out in six centres in five European countries.

According to the World Health Organization (WHO) more than seven million people die each year from cancer worldwide. This figure represents the 13% of deaths. Beyond genetic alterations, There is a growing number of alterations epigenetic which have become characteristics of the disease.

In order to fight against cancer from this new point of view, scientists from all over the world recognize the need for new research strategies. In this context, in January of 2008 the project was born CANCERDIP, as a joint effort of the major European groups. Its main objectives were to characterize the cancer epigenetic mechanisms (especially with regard to colon cancer and leukemia) and making maps with epigenetic modifications that lead to disease.

Punctuation marks

Epigenetics comprises the chemical marks which are added to the DNA and proteins that packaged it, leg to regulate its activity. The brand more recognized Epigenetics is the DNA methylation, a process that is based on the addition of a methyl chemical group to a part of our genetic puzzle. It is therefore, While Genetics is the alphabet, Epigenetics are the signs of punctuation of the text that give sense.

Defective DNA methylation patterns characterize the State of cancer and can be used as indicators of the behavior of the disease and its response to treatment. Participants in the project CANCERDIP they have validated a new technology to detect and isolate these tumors present epigenetic modifications, that has allowed to decrypt the footprint epigenetics of 1.628 people.

These maps are the starting point for the identification of regions with aberrant methylation and may be useful to identify the origin of a tumor or predict their behavior.

The results obtained in this project will be used to generate various bioinformatics tools. The genomic location of DNA methylation, the characteristics of the DNA sequence, and the presence of multiple epigenetic alterations will serve to generate a software able to predict the epigenetic State of genes.

The project CANCERDIP It has been funded with 3 million euros by the European Union. In total, they have participated in more than 20 Molecular and cellular biologists, experts in cancer and bioinformatics in five European countries (Spain, Belgium, Holland, Germany and Italy), organized into six research groups.

Heart Burger, healthy hamburgers

24 06 2011

Although it may seem that it is not a good time to open new establishments, There is always someone that is when you create should be strong betting business and invest precisely in "lean times" taking advantage of the gaps that remain in the sector. That is what thought Salvador mackerel and Esther Porta, two professionals with extensive experience in the hotel and catering sector decided to open few months ago Heart Burger, a burger bar in the heart of Barcelona.
And hearts will history, because your business is based on a range of hundred percent healthy hamburgers, developed with Artisan Bread and organic beef, in the form of heart. Your bet is as healthy, entrepreneurs decided to patent their original hamburgers in the shape of a heart and the idea is to end business - franchising and stakeholders are not missing, even beyond our borders-.

Heart Burger He was born after years of research and study of the sector. Esther Porta and Salvador Chicharro left their jobs at two hotels in the Costa Brava to devote himself fully to opening your own business. "We studied the sector and saw that there was no offer of quality hamburger"; so we wanted to open a local to dignify the Burger; We traveled to USA and Europe to learn the most important in this type of cuisine local and saw some very interesting things; At last, We plan a business based in healthy and high-quality burgers”, has horse mackerel. And what of "healthy" take it to the extreme, since they have developed a market study comparing their burgers from organic meat burgers of the main chains of hamburgers in the country and have been scientifically substantiated that theirs are nutritionally healthier and less caloric. "Ours have less sodium", less saturated fats and trans fats, "and more protein", Add horse mackerel. In fact, they have succeeded in that the Spanish Heart Association endorses their burgers (You can use the logo of the entity, that certifies that they are heart-healthy foods).

Heart shaped
When designing the business they wanted to differentiate also with different brand and image. Hence, as how healthy it is associated with a good cardiovascular health, they thought that their hamburgers could have heart-shaped. That was how they looked for suppliers to, In addition to providing them with high quality raw materials, they could draw up both the bread and organic heart shaped meat patties. They got him with a Baker of Palamós (Girona) and with a meat company in la Pobla de Segur (Lleida). Both vendors provide the raw materials directly between two and three times a week. "We have patented the design", Since there anything anywhere; In addition, the goal is to power local franchising, "with what we needed shielding design of hamburgers", Add Salvador Chicharro.

For the moment, the first location is located in Gran Vía of les Corts Catalanes, within walking distance of the Plaza Universitat de Barcelona, a central location, with high pedestrian traffic. The establishment, designed by Marta Aymerich, occupies what was once a Russian restaurant (Moskva), so the investment has been minimal, since they were able to take advantage of some of the facilities. "We also wanted to be sustainable in this aspect", "and may reuse the most everything that could be", Add horse mackerel, who stresses, However, that "the important thing was to get a simple environment", but it evoked a healthy diet, based on healthy salads and meat raw materials, "hence the touches of green and red colors".

And is that, Despite base their offer on burgers, Heart Burger you are purchasing a good reputation for its range of dishes for gluten-free. "We have a wide selection of gluten-free dishes". We do not want to pigeonhole in any aspect, We are not organic, or a restaurant only for people with celiac disease, "but we want to give the opportunity to all over the world to enjoy a rich and healthy menu", Add horse mackerel. Thus, as organic products only have meat, the ketchup, the wines and cavas and some beers. "We will be introducing or removing products as we see that the client meets", and so far, the whole issue of gluten-free is working very well, "hence we clearly bet on this segment", follow mackerel.

Heart Burger in figures
Local of 250 square meters (room private groups and parties)
Capacity for 54 more people 80 in the private
6 workers in kitchen and living room
Half price Burger (with accompanying fries dish) 11,50 €
Burgers: 176 kcal/100 gr.


Restauracionnews.com.com [en línea] Spain: restauracionnews.com, 7 in June of 2011, [REF. 24 June of 2011] Available on Internet:


II Congress of the health blogosphere

20 06 2011

As we mentioned last week, DOCTOPOLIS was present in the II Congress of the health blogosphere held in Madrid the past 17 and 18 June.

During the Congress, we heard very interesting projects and proposals, In addition to different views about what should be the path that should be followed by the health sector to the new technologies (and not so new) the information and communication. All views, We are left with the impression that there is a will, at least among those who were present at the Congress, expand the boundaries of the Congress and of the “Health blogosphere” towards new horizons.

As well he said, the Congress seemed almost an exercise in complacency (even of onanism, someone said, Although using another word). And it is true that those who were in the Congress already are part of a group that uses the new technologies in the health sector, the next challenge is to ensure that those who refuse even know the benefits of the use of technology, begin to do so, and we hope that they do so with such devotion as we.


II Congress of the blogosphere health analyzes the use of social networks

The phenomenon of information and communication technologies has come to the health sector, and you have to stay. Proof of this is that over the last year have been created 250 new health blogs at Spain and they have been groups of medical professionals to push the health at the same time that hospitals have created their own social networks and have participated in existing ones. Despite advances experienced, “the use has not been extended to all parties, Although the beginning is hopeful”, points Juan del Llano, Director of the Gaspar Casal Foundation and a member of the Organizing Committee of the II Congress of the blogosphere Saniatria.

Diariomedico.com [en línea] Spain: diariomedico.com, 20 in June of 2011, [REF. 20 June of 2011] Available on Internet:


Biotechnology entrepreneurs with greater projection of Spain

16 06 2011

Can a company of three people be able to manufacture scientific equipment with which investigates on living tissue regeneration?? Or a group of four people have developed an aerial robot responsible for solve the problem posed by birds at airports?, landfill or agricultural plantations? It sounds like science fiction, and more specific to large multinational business projects in r & d than Spanish micro with just three years of life.

But the truth is that Spain has a large network of entrepreneurs in the biotechnology sector que “not only is a pointer, but also numerous”, in the words of Emilio Muñoz, President of the Scientific Committee of Asebio, employers in this sector. “We have cutting-edge advances in many areas: Neuroscience, agricultural, industrial, power…”. Conclusion?? Spain seems to have a good quarry of biotechnology entrepreneurship. They serve various data to illustrate. The first, que WhatIt is an industry that moves more than 50.000 million. The second, that the 88% companies operating in has an international aspect. And the third, What “the number of personnel in r & d in biotechnology has reached the 6.841 professionals in 2009, the 6,86% more than the previous year. In terms of the total employment in enterprises with biotechnology-related activities, reached the 148.648 people in 2009, a 37,2% more”.

There are ideas, There is talent… and there is also recognition. In fact, in this year's Edition of the Awards entrepreneur XXI, organized by La Caixa and cootorgados by the Ministry of industry, who every year choose the best projects of entrepreneurship in each autonomous community, biotechnology has had a prominent place. Companies newly created less than ten employees are able to develop leading projects at the international level within your activity. Below, some of the best projects of biotechnology entrepreneurship Spain.

With less than two years of life and only three employees in payroll, Ebers is dedicated to manufacture “scientific instruments for research in engineering and tissue“, According to Pedro Moreo, one of its founders. “In a few years, it is expected that they can regenerate tissues and organs, and we will take care of providing material for such investigations”.

I.e., a small Aragonese company involved as a provider in the challenge of develop in vitro organ and tissue that can be used to replace others that are damaged or have ceased to be functional. How can a company as recently? (founded at the end of 2009) and too small to compete in the area of the frontier science? “We are small that develop these things. Then, When the projects mature, It is when there are large corporations and you buy”.

Ebers has been the project of entrepreneurship that has won the Prize EmprendedorXXI in Aragon, category emprendesXXI, destined for newly created societies. “The hardest thing for us is the theme of the sales, because we are scientific training, non-commercial”, affects Moreo, for those who “the issue of the funding is not the aspect most limiting us, because I always say that a good idea always finds financing”.

From Asebio affect that, Despite the fact that “Spanish venture capital usually does not invest large amounts in biotechnological Spanish and there is no bank loans because in Spain the financial sector does not understand innovation”, as points out Emilio Muñoz, There are public programs to encourage the implementation of such companies. “The Ministry of science and innovation has said that over deeste year, through different programs, go 280 EUR million to the health sector, with special emphasis in the field of r & d biopharmaceutical”.

Raptor bird
Imagine found at foot of track at an airport and, to look up, is a robotic flying in circles bird. A robot bird-shaped?? Seems like something out of a futuristic movie, but that is what they have created at Bird Raptor international, another of the micro- leading SMEs in biotech venture.

It's like a scarecrow adapted“, summarizes Victor Garcia, one of the four people that make up the company. “Created it in 2008, from studies of the ornithologist Paolo Iori, I didn't understand how it is possible that is still used traditional falconry to chase away birds at airports “. García thus refers to the use of Falcons trained to eradicate bird populations that may affect aircraft flight tracks. And what was what raised Bird Raptor international?? Something as futuristic as a robot. “It is a project combining aeronautical, industry and environment”. It is actually a power robotic bird that mimics an azor for a deterrent effect on seagulls, doves or starlings.

“We have a few 45 robots around the world: Peru, Colombia, Israel, Costa Rica and also Spain and Italy. We provide airports, landfills and fish farms the appliance and the necessary training to handle it. In the long run it is more profitable than using falcons, because you can have flying wherever makes you need”.

Unlike Moreo, of Ebers, Garcia Yes considers that the funding is a very profound obstacle to biotechnology entrepreneurship on a small scale. “Banks will not finance unless you hipoteques you. We were lucky to find a business angel and also got support of Enisa and a grant from the Government of the Balearic Islands”. In his opinion, “the first three years are the most complicated, and when your clients are scattered all over the world, because you have to travel a lot and commercial costs soar”.

Garcia is convinced that “If investors, banks and venture capital were a small business projects, would be very interesting niche markets”. And it is that you for this entrepreneur, There is an important base of human capital able to develop leading projects in the area of biotechnology without requiring large corporate structures.

For this reason, fly over the fear of a possible leak of talent to other markets. “In United States, for example, banks if you financed the feasibility to present your project, not of warranties personales”, points.

From Asebio, the Chairman of its Scientific Committee adds that “is a shame to see how good professionals who have studied here go to other countries with more opportunities and higher salaries. We hope that the culture of innovation is implemented once for all in Spain and generate attractive opportunities for the bioemprendedores, which would lead to the creation of many more technology-based companies”.

Some entrepreneurs in the biotechnology area believe that being small does not have to be a disadvantage, When is compensated with “be agile”, as points out Miguel Roncalés, CEO of AlphaSip, Another Zaragoza micropyme that, with seven employees in payroll, dedicated to producing for medical diagnostics nanoelectronic biosensors. In this search for agility, languages are fundamental: “English is spoken in our Office, French and Spanish. This capability to collaborate internationally makes us frankly competitive”.

Thanks to this ability, the company works with the National Center of microelectronics in Barcelona (NJC), with the Department of microfluidics of the Unviersidad of Zaragoza and the Department of analytical chemistry of the Complutense University of Madrid within Spain. In Europe he collaborated with the German Fraunhofer Institute Institute and the laboratory of Photonics and nanostructures France, at the same time that collaborates with large French semiconductor companies, German and Dutch, According to count those responsible. The main landmark of the company, to date, is a device oriented monitoring patients with heart problems. “Large laboratories with which we are talking about are frankly interested. In the same way are the hospitals and the doctors with whom we are validating our products”.

What is the biggest problem you have encountered this micropyme?, you have less than two years of life? “The tricky thing is, without a doubt, building connection bridges between the business world and the scientific. As it is logical, scientists have a way of working according to your training. In the business world, more focused on economic results, We have another way to operate”.

In regards to the search for funding, Speakers believed that entrepreneurs contests are a good opportunity. They have been one of the winners of the Award EmprendedorXXI, an award that “us it is already opening doors to funding, Since we are speaking with Iese business angels, as well as with the background of risk Capital of la Caixa. The fact to be rewarded is also giving us visibility, Since the access to the information through the Internet is already instant”.

Expanding the range of the number of employees, but without leaving out the niche of small business, Agnitio is, a society of 25 employees who last year had a turnover of more than 2,7 million euros with its security technology. What it is?? In use biological aspects, as speech recognition or fingerprint for, for example, check whether a certain test of voice belongs to the accused in forensic laboratories.

Also applied this method to develop security mechanisms such as key to open a door, or access to a bank account. Agnitio has six years of life and a dozen international patents. According to data of the company, your solution has a 99% efficiency in recognition of the voice of the user, regardless of the language and the used channel.

Agnitio is an example of how a project of these characteristics can grow and consolidate on the international scene in a few years. “Biotechnology must be one of the engines that drive the economy in Spain“, Add Emilio Muñoz, President of the Scientific Committee of Asebio, “Since its base is innovation, and this is precisely what the country needs to recover. Now, you just need to give us more opportunities to succeed, Since the benefits of biotechnology in the economy are multiple by the cross-cutting nature of business and the application of technological knowledge in these sectors”.

Muñoz, of Asebio, It considers that the field of biomedicine is one of the most active in this sector. “Just edit a pipeline biohealth including to 54 companies that provide a total of 200 projects relating to medicines and Diagnostics for human use systems and 13 for animal health products”.

By areas of activity, the President of the Scientific Committee of Asebio highlights “Neuroscience, in particular, for the treatment of the disease of Alzheimer's disease and Oncology“. One of the most outstanding in this area SMEs is Neuron, whose research focuses on the discovery of neuroprotective drugs and preventive enfermenades as Alzheimer's. Neuron, with five years on the market, It is currently listed on the alternative stock market (MAB). “Exit to the MAB or create large companies with licensing agreements are good ways to be financed”, Adds Muñoz.

Who at the moment have not done is BioncoTech, an SME in Paterna created just a year ago that, with its four employees, working on the development of a new concept of cancer therapy for the treatment of aggressive tumors such as metastatic melanoma, bladder cancer or pancreatic cancer, diseases that do not have an effective treatment. In this way, a small company strives to cover a medical necessity so far exempt from solution.

Despite its limited travel (a year on the market), It has already won several awards, among them the EmprendedorXXI in the Valencian Community and the V Prize Foundation Biogen Idec young researchers, granted to Damia Tormo Carulla, Director general of Bioncotech.

Without leaving the field bio also highlights the case of Alergenetica. Despite the fact that it is one of the longest-lived projects of those highlighted in this report (was born in 2001) It still has three employees, from his laboratory in Santa Cruz de Tenerife, they work in the development of vaccines that modify the mechanisms that cause allergies caused by fungi.

It's a long term project, because the company plans to have a vaccine between the years designed and validated 2016 and 2017. This commitment has earned to be recognized with the Award EmprendedorXXI de Canarias, category crecesXXI, for projects with a certain distance.

Fungi are also the field of study of Symborg. It's an SME Murcia, born in November of 2009, It seeks to isolate, development and marketing of micro-organisms for agricultural applications. At the moment it has already achieved a technology of production of bio-based fungi.

Spain has a quarry of entrepreneurs biotechnological able to develop leading projects at the international level. But from the employer's sector they warn of the problem of funding once started activity: “The early stages of starting a business (between 500.000 euros and two million euros) they are usually covered by public subsidies (or credits) minor capital contributions or risk or business angels. The problem lies in the following stages (2 a 5 million euros)”, Emilio Muñoz-statement from ASEAN Asebio.


Eleconomista.es [en línea] Spain: eleconomista.es, 16in June of 2011, [REF. 13 June of 2011] Available on Internet:


II Congress of the health blogosphere

13 06 2011

Then publish an article of noticiasmedicas.es innovation in health, rather than simply announce the Congress of the health blogosphere and the presence of DOCTOPOLIS in the same, because we feel that it perfectly sums up the reasons and objectives of the Congress, referring in a critical way, but at the same time very realistic, the current relationship between a part of the health sector and the Internet.

From DOCTOPOLIS we offer you our full support to the Congress and, of course, We will be present. We believe that it is a great opportunity to know each other and exchange views on the present and the future of the sector.

We take this opportunity to invite all those who want us to know that come to hear a presentation from DOCTOPOLIS on the block of Pecha Kucha on Saturday 18 to the 11:45. We will also be present later in the table of Cables 2 between the 15:15 and the 16:30.


Go new. A Congress of Internet and health in Spain.

This could be the impression of those who approach for the first time to the Congress of the health blogosphere, This year celebrates its second edition (17 and 18 of June at the Hospital Clinico San Carlos in Madrid).

Some years we live, daily, with a multitude of forums that discuss about telemedicine, applications of tecnología 2.0 for clinical management, "the"e-paciente"and other hot topics". This Congress is another roll.

At the same time the health sector experts debated on Internet and health, thousands of doctors, nurses, pharmaceutical, managers, companies, hospitals, centers of primary care and patients interact on the network a growing and unstoppable pace. The world of the Health blogosphere is so that He left obsolete the traditional media and debate of the last century formats (a table, speakers slung behind a powerpoint and, If we are lucky, questions). A single entry from the blog of some guru of these has more entries in a day than attending the majority of soirees, Conference, conferences and other face-to-face formats.

The positioning of a video, an opinion in a forum influences tremendously the criterion of the patient that comes to a health care facility conditioning, even unimaginable way, the evolution of the doctor-patient relationship. Conventional social networks and their professional development (many of them already closed doctors) they have an impact on the preferences of its users or the best line of largest pharmaceutical company sales could equal.

Science, the policy and the preferences of the paciente-contribuyente - citizen circulating on the net generating the great health debate. Media read bloggers to create news and online communication corporations constantly investigating how to channel all information that is generated and shared therein related to health, health and medicine. And all this in the eyes of those who, naive, "they argue that"The Internet is the future”. Internet was the future makes 15 years, a decade ago that is the present.

Why, because there is a health e-Vida increasingly intensive, last year was the I Congress of the health blogosphere with vocation of becoming an independent space to share all the initiatives, public and private, that they had to support Internet. An open forum would serve as a showcase to learn about what was happening on the Internet in relation to the health sector and what could be expected from the exciting world of health communication network.

The success achieved, Live followed by Twitter and Facebook by hundreds of people was starting point of this second edition, which aims to consolidate the Congress of the health blogosphere (CBS) "as a point of encounter and thermometer of the"e-sectorhealth.

Participants, face-to-face and virtual Congress, You will find tables of debate, workshops, conferences and spontaneous with cables tables spaces, flip-charts, projectors and chairs where will be presented and discussed different initiatives and projects that participants in the Conference have been sending the last months.

The Conference will include the active participation of political, journalists, responsible for communication on the Internet platforms, national and international experts in online communication, bloggers, Directors of specific social networks in the health sector, various suppliers and opinion leaders in the network, all fleeing from conventions in the form of share knowledge without compromising the rigor of the information and content, and marking is intended to accommodate all the heterogeneity of proposals that define the health e-sector.

All the members of the organizing committees of the two editions of the Congress of the health blogosphere We want to thank the hundreds of participants who have enriched these two meetings with your participation and invite all those who, in one way or other we are linked with health, to imbue in current Exchange and synergies that daily connects us to each other on the Internet. Us e - see you in June.

Noticiasmedicas.es [en línea] Spain: noticiasmedicas.es, 13 in June of 2011, [REF. 13 June of 2011] Available on Internet:


Paralyzed man stands up thanks to new therapy

9 06 2011

For the first time, a patient paralyzed from the waist down (a 25-year-old man) has been able to stand up on his own and take a few steps.

Rob Summers was a star college pitcher five years ago when a hit-and-run accident left him paralyzed from the waist down.

“When am I going to walk again?” Summers asked his doctors. Summers says his doctors told him, you’ll never walk again, or take a step, nothing.

They were wrong. Researchers working with the Christopher Reeve Foundation announced that Summers is the world’s first patient to stand using a new therapy that could fundamentally change the treatment of paralysis.

“I stood, independently, stood,” Summers says. “After not having moved anything for four years … and I stood.”

The landmark findings are published in the journal Lancet. They challenge conventional thinking that signals from the brain are needed for walking.

What we’ve really discovered is the neurons in the spinal cord can do all the same things as the nerves in the brain,” says lead study author Susan Harkema, of the University of Louisville.

Summers’ injury disrupted the nerve pathway that normally triggers walking. Researchers implanted an electrical stimulator at the base of the spine that (along with special exercises) allowed his legs to move without input from the brain.

“I stand about an hour a day,” Summers says. “I can move my toes ankles knees, hips all on command.”

He’s also made other meaningful progress, regaining bladder and sexual function. But he’s still wheelchair-bound, and doctors cannot say whether he’ll walk again on his own. But, every day, he remembers the first time he stood up.

“It’s that moment that continues to give me the hope for tomorrow, and the future for this project, and helping out millions of other people in my same situation,” Summer says.

He’s only able to take steps with help, when the stimulating device is plugged-in in the lab. So it’s nowhere near ready for widespread use.

Read more: http://www.cbsnews.com/stories/2011/05/19/eveningnews/main20064470.shtml#ixzz1OlAXKZq3


Cbsnews.com [en línea] New York (USA): cbsnews.com, 9 de junio de 2011[REF. 19 in May of 2011] Available on Internet:


Dr. MONTEAGUDO: eHealth and empowerment of patients

6 06 2011

José Luis Monteagudo Peña

Head of the research unit in telemedicine and e-health

Instituto de Salud Carlos III

Technological developments in the health sector have historically served to facilitate the diagnostic and therapeutic work of medical professionals. More recently, the development of information technology, It has allowed to develop info-structures for health practice and management. In recent years have been a major change with the capacity of Internet and other information technologies and communications to enable the practical realization of the concept of "patient empowerment" (patient empowerment). The idea of empowerment, refers to the ability of individuals to understand and actively influence your health, that translates into a more active role and greater responsibility in welfare processes, including its relationship with the professionals and health institutions.

The introduction and development of this philosophy of giving more power to the patient occurred in the context of social movements in defence of the rights of the consumer and patient activism, but also from the perspective of using it as a lever of transformation of the health care system. In fact all health authorities in advanced countries and supranational organizations as the EU include it in their strategic lines for the improvement of health systems patient empowerment. In line with these trends who has described it as a "pre-requisite for health" as well as "a proactive partnership with the patient and a self-care strategy" to improve health outcomes and quality of life among the chronically ill.

Government initiatives to increase the power of the patients have mainly approached three aspects: 1) promotion of healthy behaviors; 2) disease management processes and 3) relationships with health care providers.

In accordance with Health Consumer Powerhouse, in its report of the State in Europe (“The empowerment of the European Patient 2009”), patient empowerment indicators include the rights to choose between providers, direct access to the specialist, participation in decision-making, the right to the second opinion, access to the electronic health record own, the catalogues of ranking of suppliers and the availability of means of communication to access health information.

Internet has consolidated some time as a powerful tool to facilitate access to health information for citizens, but also for health education, behaviour change, teleconsultation and the second opinion. Today, day has a new wave of tools of e-health and emerging initiatives with a high potential for patient empowerment. These include social computing media (Web 2.0); interactive communication multichannel systems; mobile health (mHealth); of personal medical records (PHRs); AAL services (Ambient Assisted Living) for independent home living; personal health; personalized health and open, interoperable Web services with applications platforms for the (Auto) management of chronic patients and the long-term care.

In the transition to the possible scenarios of future health will be interesting to see how that will develop the technological capacities of empowerment of citizens in caring for your health, they are to be taken by the population, How to live with the processes of formal care and health professionals how to adapt to a new situation of relationship with the patients much more rich in possibilities than in the past.

Also confirms the effectiveness of the HPV vaccine in adult women

2 06 2011

Vaccine variants 6, 11, 16 y 18 human papilloma virus (HPV) also is safe and effective in women between 24 y 45 yearand. So this concludes an international study to close of 4.000 women is published in British Journal of Cancer.

Until now there were many studies that confirmed the effectiveness of the vaccine in girls of 14 a 26 años. This is the first study showing it in older women of 26 años.years

In the study, headed by Xavier Castellsagué, researcher of the Infections and ICO-IDIBELL Cancer Unit, they have participated 3819 healthy women aged between the 24 and 45 years. Half received the vaccine and the other half a placebo. From here, underwent a follow-up in which monitored the number of developed antibodies, HPV infections, preneoplastic lesions and genital warts during the 4 later years. Data from the study confirms not only the safety of the vaccine, but also its high effectiveness in preventing these infections and HPV-related injury.

The viruses and vaccines

Human papilloma virus is responsible for all tumors of neck of uterus and genital warts. This tumor is the second leading cause of death from cancer in women, behind the breast. Each year are diagnosed 500.000 cases around the world, half of them die for this cause. In Spain, occur around 2.100 cases of cancer and a few 700 deaths per year.

In recent years important progress has been in the development of preventive vaccines. The Catalan Oncology Institute It has been the only centre of Spanish who participated in clinical trials of two existing vaccines so far: a tetravalent, contra las variantes 6 / 11 / 16 y 18 the virus, and a bivalent, cagainst the variants16 yand18. Around the 70% of all tumors of the cervix are caused per these two subtypes of HPV.

Currently, are already developing new generations of vaccines that protect against a wider range of virus.

Digital Butlletí de l ’ Institut Català d ’ Oncology [en línea] Barcelona (Spain): iconcologia.NET, 02 in June of 2011, [REF. 02 June of 2011] Available on Internet: